Evaluating the Effectiveness of Prophylactic Strategies for Hemophilia A Management: A Real-World, Longitudinal Observational Study
Intermediate-dose prophylaxis effectively reduced bleeding rates and improved quality of life in patients with severe HA. Despite initial cost increases, the intervention became cost effective over time. This study provides valuable data for healthcare policymakers, highlighting the long-term benefits of prophylaxis as a preventative approach for managing bleeding and improving overall well-being in patients with severe HA.
Authors
- Leanne Lai (ORCID: https://orcid.org/0000-0003-0419-4247)
- Te‐Fu Weng
- Yu‐Mei Liao (ORCID: https://orcid.org/0000-0001-9916-9356)
- Ming‐Ching Shen (ORCID: https://orcid.org/0000-0001-7789-2148)
- Sheng‐Chieh Chou (ORCID: https://orcid.org/0000-0002-4121-019X)
- Shyh‐Shin Chiou (ORCID: https://orcid.org/0000-0001-7639-9116)
- Jiaan‐Der Wang (ORCID: https://orcid.org/0000-0002-7908-4969)
- Ching‐Yeh Lin (ORCID: https://orcid.org/0000-0002-4371-974X)
- Pei‐Chin Lin (ORCID: https://orcid.org/0000-0003-3895-9500)
- Ching‐Tien Peng
Institutions
- Kaohsiung Medical University (TW)
- Tunghai University (TW)
- China Medical University (TW)
- Kaohsiung Medical University Chung-Ho Memorial Hospital (TW)
- Taichung Veterans General Hospital (TW)
- Chung Shan Medical University Hospital (TW)
- China Medical University Hospital (TW)
- National Taiwan University Hospital (TW)
- Taiwan Society of Thrombosis and Hemostasis (TW)
- Changhua Christian Hospital (TW)
Publication Details
- Journal
- Drugs - Real World Outcomes
- Published
- 2024-11-20
- DOI
- https://doi.org/10.1007/s40801-024-00452-z
- Citations
- 1
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- Kaohsiung Medical University